These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 38009816)
1. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation. Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816 [TBL] [Abstract][Full Text] [Related]
2. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway. Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266 [TBL] [Abstract][Full Text] [Related]
3. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway. Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585 [TBL] [Abstract][Full Text] [Related]
4. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy. Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585 [TBL] [Abstract][Full Text] [Related]
5. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model. Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241 [TBL] [Abstract][Full Text] [Related]
6. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397 [TBL] [Abstract][Full Text] [Related]
7. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice. Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199 [TBL] [Abstract][Full Text] [Related]
8. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia. Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335 [TBL] [Abstract][Full Text] [Related]
9. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
10. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1. He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895 [TBL] [Abstract][Full Text] [Related]
11. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia. Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133 [TBL] [Abstract][Full Text] [Related]
12. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling. Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105 [TBL] [Abstract][Full Text] [Related]
13. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model. Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway. Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
16. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model. Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652 [TBL] [Abstract][Full Text] [Related]
17. Taurine Rescues Cancer-induced Atrophy in Human Skeletal Muscle Cells Chen CH; Chen YC; Chang YC; Hung CH; Huang CY; Tsai CL; Sun CK; Lin HY Anticancer Res; 2024 May; 44(5):1963-1971. PubMed ID: 38677769 [TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837 [TBL] [Abstract][Full Text] [Related]
19. Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy. Kim HJ; Lee JH; Kim SW; Lee SH; Jung DW; Williams DR PLoS One; 2021; 16(5):e0252135. PubMed ID: 34038481 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway. Wang Y; Sun X; Yang Q; Guo C Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]